Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis
- 31 December 2012
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 12 (2), 318-322
- https://doi.org/10.1016/j.autrev.2012.05.007
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The influence of ACPA status and characteristics on the course of RANature Reviews Rheumatology, 2012
- Anti-CCP antibodies: the past, the present and the futureNature Reviews Rheumatology, 2011
- Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritisArthritis Research & Therapy, 2011
- All you wanted to know about anti-CCP but were afraid to askAutoimmunity Reviews, 2010
- Rheumatoid arthritisThe Lancet, 2010
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals Of The Rheumatic Diseases, 2010
- Anti–cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive valueArthritis & Rheumatism, 2009
- Synthetic Peptides: The Future of Patient Management in Systemic Rheumatic Diseases?Current Medicinal Chemistry, 2007
- Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2007
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.JCI Insight, 1998